 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This price move could indicate a change in the trend, and may be a sell signal for investors...

Kamada (KMDA, $5.17) price exceeded its 50-day Moving Average on September 22, 2023

Kamada (KMDA, $5.14) price exceeded its 50-day Moving Average on September 12, 2023

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Kamada files to sell $50M of ordinary shares

This is a Bearish indicator signaling KMDA's price could decline from here. Traders may explore shorting the stock or put options...

Kamada (KMDA, $5.38) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 6, 2023

StockNews.com upgraded shares of Kamada (NASDAQ:KMDA Free Report) from a hold rating to a buy rating in a research report sent to investors on Wednesday. Several other equities research analysts have also recently commented on KMDA. TheStreet raised shares of Kamada from a d+ rating to a c- rating ...

Kamada (NASDAQ:KMDA) Upgraded by StockNews.com to Buy

Kamada appoints Benjamin Dekel, Assaf Itshayek to board of directors

Kamada announces shareholder approval for private placement

Funding Strengthens Kamadas Financial Position, Supporting its Growth Plans and the Pursuit of Strategic Business Development OpportunitiesAppointment of Two New Independent Directors to its Board: Professor Benjamin Dekel and Mr. Assaf Itshayek REHOVOT, Israel and HOBOKEN, N.J., Aug. 30, 2023 (...

Kamada Announces Shareholder Approval and Planned Closing of $60 Million Private Placement with FIMI Opportunity Funds

Kamada Ltd. (NASDAQ:KMDA  Free Report)  Equities researchers at HC Wainwright dropped their Q3 2023 earnings estimates for Kamada in a note issued to investors on Thursday, August 17th. HC Wainwright analyst A. Fein now anticipates that the biotechnology company will post earnings per ...

Q3 2023 EPS Estimates for Kamada Ltd. (NASDAQ:KMDA) Lowered by Analyst

Kamada Ltd. (NASDAQ:KMDA Free Report) Investment analysts at HC Wainwright lowered their Q3 2023 earnings estimates for shares of Kamada in a note issued to investors on Thursday, August 17th. HC Wainwright analyst A. Fein now forecasts that the biotechnology company will post earnings per share of...

Q3 2023 Earnings Estimate for Kamada Ltd. (NASDAQ:KMDA) Issued By HC Wainwright

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Watchers	2,037
52-Wk Low	$3.72
52-Wk High	$5.85

Market Cap	$226.43M
Volume (M)	3,448.00
52-Wk High	$5.85
52-Wk Low	$3.72

KMDA Kamada Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals